May 12, 2020
The publication of the first human genome sequence more than 15 years ago marked the start of a new era in medicine. In the years since then, researchers have greatly expanded knowledge of gene-disease links and gained a better understanding of the underlying molecular pathways.
The first precision therapies, targeted to specific molecular alterations, are already available. Despite this progress, the lack of diversity in genetic databases limits the potential benefits and markets for these advances. To further grow the field of precision medicine, much more knowledge is needed of the global diversity found in the human genome.
By Sumit Jamuar, Dr Jonathan Picker, Dr Saumya Jamuar, &
Dr Yaron Turpaz
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: